Skip to main content

Global Bioenergies – Successful scale-up of Pomacle commercial unit

Written by Customer Service on . Posted in Public Companies.

        

Successful scale-up of Pomacle commercial unit

Evry, 06 December 2022 – Global Bioenergies announces the successful scale-up of production at its Pomacle commercial unit. All sub-units are now up and running, a few weeks ahead of schedule.

Global Bioenergies announces that its first commercial production unit is now fully operational. All units (biological isobutene production, purification, condensation and packaging) have been validated and are now in operation.

Frédéric Ollivier, Global Bioenergies’ Chief Technical Officer, said: “An industrial project is invariably an adventure. This is especially so in these troubled times. Nevertheless, we were able to successfully build and commission the unit in very good conditions. We are now producing about 1 tonne of isobutene per week. I would like to congratulate the entire Global Bioenergies team, who made this success possible.”

Global Bioenergies plans to sell purified isobutene for use in cosmetics and high value-added fuel applications that can cover what remains a very high production cost.

Global Bioenergies will also convert some of the isobutene produced, via an established chain of tollers, into cosmetic-grade isododecane for sale to major cosmetic companies under the trademark Isonaturane® 12. The scale-up of this downstream chain was executed in parallel to the start of operations at the Pomacle unit.

Daphne Galvez, Global Bioenergies’ Head of Sales, said: “We will produce Isonaturane® 12 by campaigns. The first batch, which will be delivered in a few months, has already been sold in full, and our commercial discussions are now focusing on subsequent batches.”

Marc Delcourt, Global Bioenergies’ Chief Executive Officer, said: “The primary purpose of this unit is to generate revenue. Its second purpose is to pave the way in commercial, technical and regulatory terms for the 2025 launch of a new unit destined to produce 2,000 tonnes of isobutene and derivatives per year.”

About GLOBAL BIOENERGIES

Global Bioenergies converts plant-derived resources into compounds used in the cosmetics industry, as well as the energy and materials sectors. After launching the first long-lasting and natural make-up brand LAST® in 2021, Global Bioenergies is now marketing Isonaturane® 12, its key ingredient, to major cosmetics companies to improve the naturalness of their formulas whilst improving their carbon footprint. In the long run, Global Bioenergies is also aiming at cutting CO2 emissions in the aviation and road sector and thereby curb global warming. Global Bioenergies is listed on Euronext Growth Paris (FR0011052257 – ALGBE).

Receive information about Global Bioenergies directly by subscribing to our news feed on www.global-bioenergies.com

Follow us on LinkedIn: Global Bioenergies

Contacts

GLOBAL BIOENERGIES

 

invest@global-bioenergies.com

 

PRESS RELATIONS

 

Iva Baytcheva
ibaytcheva@ulysse-communication.com

 

Nicolas Daniels
ndaniels@ulysse-communication.com

 

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.